Suppr超能文献

[急诊科高钾血症的治疗及与预后相关的因素]

[Treatment and factors associated with prognosis of hyperkalemia in the emergency department].

作者信息

Wu Yao, Fu Yangyang, Tang Hanqi, Lei Meng, Hao Wenlin, Zhu Huadong, Xu Shengyong, Xu Jun, Yu Xuezhong

机构信息

Department of Emergency, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100730, China. Corresponding author: Xu Shengyong, Email:

出版信息

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023 Mar;35(3):321-325. doi: 10.3760/cma.j.cn121430-20220711-00653.

Abstract

OBJECTIVE

To survey treatment and prognosis of hyperkalemia patients in the emergency department and to analyze factors associated with all-cause in-hospital mortality.

METHODS

We implemented electronic hospital information system, extracted demographic characteristics, underlying diseases, laboratory findings, potassium lowering therapy and prognosis of hyperkalemia patients [age ≥ 18 years, serum potassium (K) concentration ≥ 5.5 mmol/L] in the emergency department of Peking Union hospital in Beijing between June 1st 2019 to May 31st 2020. The enrolled subjects were divided into the non-survival group and the survival group according to their prognosis. Univariate analysis and Cox regression model were adopted to analyze factors affecting all-cause in-hospital mortality of hyperkalemia patients.

RESULTS

A total of 579 patients [median age 64 (22) years; 310 men (53.5%) and 269 women (46.5%)] with hyperkalemia were enrolled, among which, 317 (54.7%), 143 (24.7%) and 119 (20.6%) were mild, moderate, and severe hyperkalemia, respectively. 499 (86.20%) patients received potassium-lowering therapy, forty-four treatment regimens were administered. Insulin and glucose (I+G, 61.3%), diuretics (Diu, 57.2%), sodium bicarbonate (SB, 41.9%) and calcium gluconate/chloride (CA, 44.4%) were commonly used for the treatment of hyperkalemiain the emergency department. The combination of insulin and glucose, calcium gluconate/chloride, diuretics and sodium bicarbonate (I+G+CA+Diu+SB) was the most favored combined treatment regimen of hyperkalemia in the emergency department. The higher serum potassium concentration, the higher proportion of administrating combined treatment regimen and/or hemodialysis (HD) (the proportion of administrating combined treatment regimen in mild, moderate, and severe hyperkalemia patients were 58.4%, 82.5% and 94.8%; the proportion of administrating HD in mild, moderate, and severe hyperkalemia patients were 9.7%, 13.3% and 16.0%, respectively). The proportion of achievement of normokalaemia elevated as the kinds of potassium lowering treatment included in the combined treatment regimen increased. The proportion of achievement of normokalaemia was 100% in the combined treatment regimen including 6 kinds of potassium lowering therapy. Among various potassium lowering treatments, HD contributed to the highest rate of achievement of normokalaemia (93.8%). 111 of 579 (19.20%) hyperkalemia patients died in hospital. Cox regression model revealed that complicated with cardiac dysfunction predicted higher mortality [hazard ratio (HR) = 1.757, 95% confidence interval (95%CI) was 1.155-2.672, P = 0.009]. Achievement of normokalaemia and administration of diuretics attributed to lower mortality (HR = 0.248, 95%CI was 0.155-0.398, P = 0.000; HR = 0.335, 95%CI was 0.211-0.531, P = 0.000, respectively).

CONCLUSIONS

Treatment of hyperkalemia in the emergency department were various. Complicated with cardiac dysfunction were associated with higher mortality. Achieving normokalaemia was associated with decreased mortality.

摘要

目的

调查急诊科高钾血症患者的治疗及预后情况,并分析与全因院内死亡率相关的因素。

方法

利用医院电子信息系统,提取2019年6月1日至2020年5月31日期间北京协和医院急诊科高钾血症患者[年龄≥18岁,血清钾(K)浓度≥5.5 mmol/L]的人口统计学特征、基础疾病、实验室检查结果、降钾治疗情况及预后。根据预后将纳入的研究对象分为未存活组和存活组。采用单因素分析及Cox回归模型分析影响高钾血症患者全因院内死亡率的因素。

结果

共纳入579例高钾血症患者[年龄中位数64(22)岁;男性310例(53.5%),女性269例(46.5%)],其中轻度、中度、重度高钾血症患者分别为317例(54.7%)、143例(24.7%)和119例(20.6%)。499例(86.20%)患者接受了降钾治疗,共采用了44种治疗方案。急诊科治疗高钾血症常用的药物有胰岛素和葡萄糖(I+G,61.3%)、利尿剂(Diu,57.2%)、碳酸氢钠(SB,41.9%)和葡萄糖酸钙/氯化钙(CA,44.4%)。胰岛素和葡萄糖、葡萄糖酸钙/氯化钙、利尿剂及碳酸氢钠联合使用(I+G+CA+Diu+SB)是急诊科最常用的高钾血症联合治疗方案。血清钾浓度越高,采用联合治疗方案和/或血液透析(HD)的比例越高(轻度、中度、重度高钾血症患者采用联合治疗方案的比例分别为58.4%、82.5%和94.8%;采用HD的比例分别为9.7%、13.3%和16.0%)。联合治疗方案中包含的降钾治疗种类越多,血钾正常化的比例越高。包含6种降钾治疗的联合治疗方案中血钾正常化的比例为100%。在各种降钾治疗中,HD使血钾正常化的比例最高(93.8%)。579例高钾血症患者中有111例(19.20%)死于医院。Cox回归模型显示,合并心功能不全预示着更高的死亡率[风险比(HR)=1.757,95%置信区间(95%CI)为1.155 - 2.672,P = 0.009]。血钾正常化及使用利尿剂与较低的死亡率相关(HR分别为0.248,95%CI为0.155 - 0.398,P = 0.000;HR为0.335,95%CI为0.211 - 0.531,P = 0.000)。

结论

急诊科高钾血症的治疗方法多样。合并心功能不全会增加死亡率。血钾正常化与死亡率降低相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验